Cargando…

Let’s talk about mucormycosis emergency with COVID-19: Invest in future

Despite recent breakthroughs in the detection and treatment during the COVID-19 pandemic, mucormycosis is a serious infection with a high death rate. It is a filamentous fungal infection from the zygomycetes class of order mucorales. It is a fatal fungal infection with a 50% or higher overall fatali...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Kamlesh, Arora, Jyoti, Yadav, Parvin K., Rohilla, Kusum K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051722/
https://www.ncbi.nlm.nih.gov/pubmed/35495848
http://dx.doi.org/10.4103/jfmpc.jfmpc_1083_21
_version_ 1784696624702816256
author Malik, Kamlesh
Arora, Jyoti
Yadav, Parvin K.
Rohilla, Kusum K.
author_facet Malik, Kamlesh
Arora, Jyoti
Yadav, Parvin K.
Rohilla, Kusum K.
author_sort Malik, Kamlesh
collection PubMed
description Despite recent breakthroughs in the detection and treatment during the COVID-19 pandemic, mucormycosis is a serious infection with a high death rate. It is a filamentous fungal infection from the zygomycetes class of order mucorales. It is a fatal fungal infection with a 50% or higher overall fatality rate. Mucormycosis is a fungal infection caused by mucor, which is a mold that can be found in soil, rotting fruits, and vegetables. It can primarily affect the brain, lungs, and sinuses. It is very much fatal in patients with diabetes or who are highly immunocompromised such as patients with cancer. In addition to more than 50% mortality rate, surgical intervention may require necrotic tissue removal, which leads to severely disfiguring surgery.
format Online
Article
Text
id pubmed-9051722
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-90517222022-04-30 Let’s talk about mucormycosis emergency with COVID-19: Invest in future Malik, Kamlesh Arora, Jyoti Yadav, Parvin K. Rohilla, Kusum K. J Family Med Prim Care Commentary Despite recent breakthroughs in the detection and treatment during the COVID-19 pandemic, mucormycosis is a serious infection with a high death rate. It is a filamentous fungal infection from the zygomycetes class of order mucorales. It is a fatal fungal infection with a 50% or higher overall fatality rate. Mucormycosis is a fungal infection caused by mucor, which is a mold that can be found in soil, rotting fruits, and vegetables. It can primarily affect the brain, lungs, and sinuses. It is very much fatal in patients with diabetes or who are highly immunocompromised such as patients with cancer. In addition to more than 50% mortality rate, surgical intervention may require necrotic tissue removal, which leads to severely disfiguring surgery. Wolters Kluwer - Medknow 2022-03 2022-03-10 /pmc/articles/PMC9051722/ /pubmed/35495848 http://dx.doi.org/10.4103/jfmpc.jfmpc_1083_21 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Commentary
Malik, Kamlesh
Arora, Jyoti
Yadav, Parvin K.
Rohilla, Kusum K.
Let’s talk about mucormycosis emergency with COVID-19: Invest in future
title Let’s talk about mucormycosis emergency with COVID-19: Invest in future
title_full Let’s talk about mucormycosis emergency with COVID-19: Invest in future
title_fullStr Let’s talk about mucormycosis emergency with COVID-19: Invest in future
title_full_unstemmed Let’s talk about mucormycosis emergency with COVID-19: Invest in future
title_short Let’s talk about mucormycosis emergency with COVID-19: Invest in future
title_sort let’s talk about mucormycosis emergency with covid-19: invest in future
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051722/
https://www.ncbi.nlm.nih.gov/pubmed/35495848
http://dx.doi.org/10.4103/jfmpc.jfmpc_1083_21
work_keys_str_mv AT malikkamlesh letstalkaboutmucormycosisemergencywithcovid19investinfuture
AT arorajyoti letstalkaboutmucormycosisemergencywithcovid19investinfuture
AT yadavparvink letstalkaboutmucormycosisemergencywithcovid19investinfuture
AT rohillakusumk letstalkaboutmucormycosisemergencywithcovid19investinfuture